Sandoz wins appeal of $26.3M infringement ruling in IP battle over Lexapro
Intellectual Property 2020-08-04 3:05 pm By Miklos Bolza | Sydney
Please login to bookmark Close

Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling antidepressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au